Will Fitzgibbon - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Will Fitzgibbon's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Will Fitzgibbon

Will Fitzgibbon

Verified

Senior Reporter and Partnership Coordinator, The Examination

Washington

Journalist Type

-

Seniority Positions

Industries

Medium Formats

Content

Total articles 750

  • US private equity invests in chemical industry tied to global lead poisoning, worrying health experts

    By Will Fitzgibbon Verified|The ExaminationU.S. private equity firms have bought up producers and distributors of a chemical compound known to cause brain damage, cancer and other illnesses, according to a new report. Blackstone and American Securities LLC, who control assets worth billions of dollars, have in recent years acquired operations in Canada and elsewhere that sell lead chromate, a toxic powder used in paint, on roads and machinery, and even in food, to brighten colors, add weight or withstand high temperatures.

    By Will Fitzgibbon Verified · 0

    Sep. 25, 2024

  • How Investigative Journalists Can Fight Back Against Health Misinformation

    By Will Fitzgibbon Verified, Mia Malan Verified|Global Investigative Journalism NetworkVerifiedImagine that just four industries were responsible for one-third of global deaths every year, but that this went underreported in the news. This isn’t fiction, but our reality, argued Will Fitzgibbon, at a panel on investigative health reporting at the 2024 International Journalism Festival in Perugia, Italy. Fitzgibbon is a senior reporter and global partnership coordinator for The Examination, a new investigative health journalism outlet based in the US.

    By Will Fitzgibbon Verified, Mia Malan Verified · Global Investigative Journalism Network

    Jun. 10, 2024

  • US private equity invests in chemical industry tied to global lead poisoning, worrying health experts

    By Will Fitzgibbon Verified|The ExaminationU.S. private equity firms have bought up producers and distributors of a chemical compound known to cause brain damage, cancer and other illnesses, according to a new report. Blackstone and American Securities LLC, who control assets worth billions of dollars, have in recent years acquired operations in Canada and elsewhere that sell lead chromate, a toxic powder used in paint, on roads and machinery, and even in food, to brighten colors, add weight or withstand high temperatures.

    By Will Fitzgibbon Verified · 0

    Sep. 25, 2024

As seen in

Company Info

The Examination

The Examination is an independent nonprofit newsroom dedicated to investigating preventable health threats and empowering communities at risk. It operates globally, focusing on systemic health inequities linked to industrial practices that contribute to significant mortality rates. The organization emphasizes the needs of marginalized populations affected by issues like smoking, processed food consumption, and air pollution. The Examination produces evidence-based investigative journalism that exposes health risks and corporate practices. It collaborates with news organizations worldwide to enhance the impact of its reporting and engages directly with communities to advocate for accountability. Its primary outputs include in-depth investigative reports and educational resources that inform public discourse and propose solutions to health challenges. The organization is supported by various funders and maintains editorial independence, ensuring its work prioritizes public interest over profit.

Oregon, United States

+1 227-241-4325

Founded: 2023